Theragen Etex Co.,Ltd. (KOSDAQ:066700)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,035.00
+73.00 (3.72%)
At close: Jul 31, 2026

Theragen Etex Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
272,927271,590249,625216,470190,769166,567
Revenue Growth
5.78%8.80%15.32%13.47%14.53%16.46%
Gross Profit
141,212141,013125,981100,12677,40661,175
Operating Income
7,65810,21311,64611,47311,853-7,427
Net Income
9,73010,600-40,98526,2119,561-11,854
Earnings Per Share
259.72290.00-1281.00818.97297.86-371.00
EPS Growth
---174.95%--

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
39,58938,02524,18323,28021,42113,602
Total Debt
42,44241,64550,47636,29731,22236,743
Net Cash (Debt)
-2,853-3,620-26,293-13,016-9,801-23,141
Net Cash Growth
------
Net Cash Per Share
-75.65-98.43-821.80-406.70-306.23-723.30

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
10,73510,9721,78812,1259,5934,007
Capital Expenditures
-2,718-2,576-11,392-4,797-4,193-2,749
Free Cash Flow
8,0178,396-9,6047,3285,4011,257
Free Cash Flow Growth
---35.69%329.54%-87.69%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
51.74%51.92%50.47%46.25%40.58%36.73%
Operating Margin
2.81%3.76%4.67%5.30%6.21%-4.46%
Pretax Margin
5.90%6.46%-17.29%15.13%7.26%-7.61%
Profit Margin
3.56%3.90%-16.42%12.11%5.01%-7.12%
FCF Margin
2.94%3.09%-3.85%3.38%2.83%0.76%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.8410.94-5.4614.80-
Forward PE
-111.48111.48111.48111.48111.48
P/FCF Ratio
9.3113.81-19.5226.19163.17
PS Ratio
0.270.430.400.660.741.23